Organization
Mt Sinai, Ontario, Canada
1 abstract
Abstract
BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDY Org: Eli Lilly and Company, Indianapolis, United States, Mt Sinai, Ontario, Canada,